EW:NYSE
Edwards Lifesciences Corp
$86.44
arrow_downward
-1.39%(-1.22) 1D
Jun 3, 11:58:36 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$87.63
High
$87.90
Low
$85.80
Mkt. cap
49.77B
Avg. vol.
5.43M
Volume
1.18M
P/E ratio
46.07
52-wk high
$89.14
52-wk low
$72.30
EPS
$1.88
Beta
0.87
Shares outstanding
575.80M
No. of employees
16K
Open
$87.63
High
$87.90
Low
$85.80
Mkt. cap
49.77B
Avg. vol.
5.43M
Volume
1.18M
P/E ratio
46.07
52-wk high
$89.14
52-wk low
$72.30
EPS
$1.88
Beta
0.87
Shares outstanding
575.80M
No. of employees
16K
News stories
From sources across the web
https://www.thekeyexecutives.com/
·
8 hours ago
Edwards Lifesciences Appoints Theodora Mistras as Chief Financial Officer
Investing.com Australia
·
1 day ago
TD Cowen raises Edwards Lifesciences stock price target on TAVR market share gains By Investing.com
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Websiteedwards.com
AI content may include mistakes. Learn more